Doxifluridine in Colorectal Cancer Patients Resistant to 5-Fluorouracil (5-FU) Containing Regimens

Author： Bajetta E.   Di Bartolomeo M.   Somma L.   Del Vecchio M.   Artale S.   Zunino F.   Bignami P.   Magnani E.   Buzzoni R.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.33, Iss.4, 1997-04, pp. : 687-690

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU)

By Van Cutsem E.   Cunningham D.   Ten Bokkel Huinink W.W.   Punt C.J.A.   Alexopoulos C.G.   Dirix L.   Symann M.   Blijham G.H.   Cholet P.   Fillet G.   Van Groeningen C.   Vannetzel J.M.   Levi F.   Panagos G.   Unger C.   Wils J.   Cote C.   Blanc C.   Herait P.   Bleiberg H.  

European Journal of Cancer, Vol. 35, Iss. 1, 1999-01 ,pp. : 54-59

Elsevier

Access to resources Recommend Favorite

Factors predicting for efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU)+/-folinic acid (FA) in a compassionate-use cohort of 370 5-FU-resistant advanced colorectal cancer (CRC) patients

By Bensmane M.A.   de Gramont A.   Brienza S.   Marty M.   Levi F.   Ducreux M.   Francois E.   Gamelin E.   Bleiberg H.   Bleuzen P.   Simon J.   Cvitkovic E.  

European Journal of Cancer, Vol. 36, Iss. 18, 2000-12 ,pp. : 2335-2343

Elsevier

Access to resources Recommend Favorite

High Dose 5-Fluorouracil (5-FU) and Folinic Acid in Advanced Colorectal Cancer Resistant to Standard Dose 5-FU Treatment: Results of a Phase II Study

By Jager E.   Klein O.   Wachter B.   Muller B.   Braun U.   Knuth A.  

European Journal of Cancer, Vol. 31, Iss. 10, 1995-09 ,pp. : 1717-1717

Elsevier

Access to resources Recommend Favorite

Different Dose Regimens of 5-Fluorouracil and Interferon- in Patients With Metastatic Colorectal Carcinoma

By Ragnhammar P.   Blomgren H.   Edler D.   Lundell G.   Magnusson I.   Sonnenfeld T.  

European Journal of Cancer, Vol. 31, Iss. 3, 1995-01 ,pp. : 315-320

Elsevier

Access to resources Recommend Favorite

High-dose chronomodulated infusion of 5-fluorouracil (5-FU) and folinic acid (FA) (FF5–16) in advanced colorectal cancer patients

By Terzoli Edmondo   Garufi Carlo   Zappalà Albina   Vanni Barbara   Pugliese Patrizia   Cappellini Giancarlo   Aschelter Anna   Perrone Maria   Giannarelli Diana  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 8, 2004-08 ,pp. : 445-452

Springer Publishing Company

Access to resources Recommend Favorite